Company Filing History:
1 out of 1 
1 out of 99 
1 out of 5,089 
Years Active: 2021-2025
Title: The Innovative Contributions of Anna Miodek
Introduction
Anna Miodek is a prominent inventor based in Orsay, France. She has made significant strides in the field of immunotherapy and electrochemical detection, holding a total of 2 patents. Her work is characterized by innovative approaches that enhance the effectiveness of medical treatments.
Latest Patents
One of her latest patents is the "Aptamer-based CAR T-cell switch." This technology provides an advanced method for controlling chimeric antigen receptor (CAR)-related immunotherapies. The aptamer-based switch utilizes a synthetic bridge molecule that combines a target-binding aptamer with a CAR-binding aptamer. This system allows for targeted immunotherapy that can be customized to any desired antigen, redirected to different targets, and adjusted according to individual patient needs. It also offers rapid switching capabilities, serves as a companion diagnostic for specific CAR therapies, and is designed to be non-immunogenic with low production costs.
Another notable patent is the "System for electrochemical detection of molecules of interest." This system focuses on 'signal-on' electrochemical detection and includes a method for implementing the detection process.
Career Highlights
Throughout her career, Anna Miodek has worked with various organizations, including Alaya.bio Inc. and Université Paris-Sud. Her contributions to these institutions have been instrumental in advancing research and development in her areas of expertise.
Collaborations
Anna has collaborated with notable colleagues such as Frédéric Mourlane and Cécile Bauche. Their teamwork has fostered an environment of innovation and creativity, leading to groundbreaking advancements in their respective fields.
Conclusion
Anna Miodek's contributions to the fields of immunotherapy and electrochemical detection exemplify her innovative spirit and dedication to advancing medical technology. Her patents reflect a commitment to improving patient care through scientific innovation.